The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01F | Macrolides, lincosamides and streptogramins | |
4
|
J01FA | Macrolides | |
5
|
J01FA09 | Clarithromycin |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 0.5 g | |
| PAREN | Parenteral | 1 g |
| Active Ingredient |
|---|
|
Clarithromycin is a semi-synthetic derivative of erythromycin A. It exerts its antibacterial action by selectively binding to the 50s ribosomal sub-unit of susceptible bacteria preventing translocation of activated amino acids. It inhibits the intracellular protein synthesis of susceptible bacteria. |
| Document | Type | Information Source | |
|---|---|---|---|
| CLAREM Film-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| CLERON Film-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| KLACID Film-coated tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| Klaricid 250mg Tablets | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| KLERIMED Film coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.